About

Weight management is the ongoing process of tracking weight over time and using long-term lifestyle strategies — healthy eating and daily physical activity — to reach and hold a healthy weight. CagriSema pairs semaglutide, a GLP-1 receptor agonist, with cagrilintide, an amylin analogue, in one weekly injection; together these two hormone mimics act on appetite and fullness signals in the body. Because both components target the biological drivers of hunger, the combination may help people lose more weight than either approach alone.